Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-007056-18Phase 4Completed
Phase 4, open-label, single-arm trial of hydroxychloroquine in discoid lupus erythematosus (DLE), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Predictors of response to hydroxychloroquine. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-007056-18.